214 related articles for article (PubMed ID: 18985676)
1. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Qualman S; Lynch J; Bridge J; Parham D; Teot L; Meyer W; Pappo A
Cancer; 2008 Dec; 113(11):3242-7. PubMed ID: 18985676
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group.
Shenoy A; Alvarez E; Chi YY; Li M; Shern JF; Khan J; Hiniker SM; Granberg CF; Hawkins DS; Parham DM; Teot LA; Rudzinski ER
Eur J Cancer; 2021 Jan; 143():127-133. PubMed ID: 33302115
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of anaplasia in childhood rhabdomyosarcoma.
Sidhom I; El Nadi E; Taha H; Elkinaai N; Zaghloul MS; Younes A; Labib R; Sabry M
J Egypt Natl Canc Inst; 2015 Jun; 27(2):83-9. PubMed ID: 25921241
[TBL] [Abstract][Full Text] [Related]
4. Anaplasia in childhood rhabdomyosarcoma: An under reported entity.
Ahuja M; Tomar R; Thakur S; Mallya V; Mandal S; Khurana N; Sarin YK
Indian J Pathol Microbiol; 2022; 65(4):864-868. PubMed ID: 36308195
[TBL] [Abstract][Full Text] [Related]
5. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
Lawrence W; Anderson JR; Gehan EA; Maurer H
Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children's Oncology Group study.
Nicol K; Savell V; Moore J; Teot L; Spunt SL; Qualman S;
Pediatr Dev Pathol; 2007; 10(2):89-97. PubMed ID: 17378682
[TBL] [Abstract][Full Text] [Related]
8. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
Smith LM; Anderson JR; Qualman SJ; Crist WM; Paidas CN; Teot LA; Pappo AS; Link MP; Grier HE; Wiener ES; Breneman JC; Raney RB; Maurer HM; Donaldson SS
J Clin Oncol; 2001 Oct; 19(20):4058-64. PubMed ID: 11600608
[TBL] [Abstract][Full Text] [Related]
9. Primary renal sarcomas in the Intergroup Rhabdomyosarcoma Study Group (IRSG) experience, 1972-2005: A report from the Children's Oncology Group.
Raney B; Anderson J; Arndt C; Crist W; Maurer H; Qualman S; Wharam M; Wiener E; Meyer W;
Pediatr Blood Cancer; 2008 Sep; 51(3):339-43. PubMed ID: 18523987
[TBL] [Abstract][Full Text] [Related]
10. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
[TBL] [Abstract][Full Text] [Related]
11. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group.
Pappo AS; Crist WM; Kuttesch J; Rowe S; Ashmun RA; Maurer HM; Newton WA; Asmar L; Luo X; Shapiro DN
J Clin Oncol; 1993 Oct; 11(10):1901-5. PubMed ID: 8410116
[TBL] [Abstract][Full Text] [Related]
12. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L
Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125
[TBL] [Abstract][Full Text] [Related]
13. Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Weiss AR; Lyden ER; Anderson JR; Hawkins DS; Spunt SL; Walterhouse DO; Wolden SL; Parham DM; Rodeberg DA; Kao SC; Womer RB
J Clin Oncol; 2013 Sep; 31(26):3226-32. PubMed ID: 23940218
[TBL] [Abstract][Full Text] [Related]
14. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
[TBL] [Abstract][Full Text] [Related]
15. Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies.
Malempati S; Hawkins DS
Pediatr Blood Cancer; 2012 Jul; 59(1):5-10. PubMed ID: 22378628
[TBL] [Abstract][Full Text] [Related]
16. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Joshi D; Anderson JR; Paidas C; Breneman J; Parham DM; Crist W;
Pediatr Blood Cancer; 2004 Jan; 42(1):64-73. PubMed ID: 14752797
[TBL] [Abstract][Full Text] [Related]
17. Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
; Lager JJ; Lyden ER; Anderson JR; Pappo AS; Meyer WH; Breitfeld PP
J Clin Oncol; 2006 Jul; 24(21):3415-22. PubMed ID: 16849756
[TBL] [Abstract][Full Text] [Related]
18. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
Rodeberg DA; Anderson JR; Arndt CA; Ferrer FA; Raney RB; Jenney ME; Brecht IB; Koscielniak E; Carli M; Bisogno G; Oberlin O; Rey A; Ullrich F; Stevens MC; Meyer WH
Int J Cancer; 2011 Mar; 128(5):1232-9. PubMed ID: 20473932
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study.
Ortega JA; Wharam M; Gehan EA; Ragab AH; Crist W; Webber B; Wiener ES; Haeberlen V; Maurer HM
J Clin Oncol; 1991 May; 9(5):796-801. PubMed ID: 2016622
[TBL] [Abstract][Full Text] [Related]
20. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
